|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
|
journal
|
March 2013 |
|
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
|
journal
|
February 2014 |
|
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
|
journal
|
June 2015 |
|
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
|
journal
|
June 2015 |
|
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
|
journal
|
September 2016 |
|
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
|
journal
|
September 2016 |
|
Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses
|
journal
|
June 2018 |
|
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
|
journal
|
August 2020 |
|
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition
|
journal
|
April 2020 |
|
A Blueprint for HIV Vaccine Discovery
|
journal
|
October 2012 |
|
When designing vaccines, consider the starting material: the human B cell repertoire
|
journal
|
August 2018 |
|
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
|
journal
|
August 2013 |
|
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
|
journal
|
May 2014 |
|
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
|
journal
|
November 2016 |
|
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
|
journal
|
January 2018 |
|
An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus
|
journal
|
April 2018 |
|
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
|
journal
|
May 2018 |
|
Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan
|
journal
|
July 2019 |
|
Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
|
journal
|
September 2020 |
|
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors
|
journal
|
October 2020 |
|
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
|
journal
|
January 2008 |
|
Cloning and expression of murine Ig genes from single B cells
|
journal
|
October 2009 |
|
Locking the Elbow: Improved Antibody Fab Fragments as Chaperones for Structure Determination
|
journal
|
February 2018 |
|
Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys
|
journal
|
February 1999 |
|
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection
|
journal
|
February 2000 |
|
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
|
journal
|
February 2000 |
|
Fc receptor but not complement binding is important in antibody protection against HIV
|
journal
|
September 2007 |
|
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
|
journal
|
March 2009 |
|
Antibody-based protection against HIV infection by vectored immunoprophylaxis
|
journal
|
November 2011 |
|
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
|
journal
|
September 2012 |
|
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
|
journal
|
March 2014 |
|
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
|
journal
|
September 2014 |
|
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
|
journal
|
February 2016 |
|
Antibody responses to envelope glycoproteins in HIV-1 infection
|
journal
|
May 2015 |
|
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
|
journal
|
June 2009 |
|
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
|
journal
|
February 2014 |
|
Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site
|
journal
|
September 2016 |
|
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
|
journal
|
February 2019 |
|
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
|
journal
|
February 2019 |
|
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
|
journal
|
February 2012 |
|
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
|
journal
|
June 2012 |
|
A mouse model for HIV-1 entry
|
journal
|
September 2012 |
|
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
|
journal
|
October 2012 |
|
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody
|
journal
|
March 2013 |
|
Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires
|
journal
|
April 2016 |
|
Anti–HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity
|
journal
|
April 2018 |
|
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models
|
journal
|
September 2020 |
|
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
|
journal
|
March 2013 |
|
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
|
journal
|
August 2017 |
|
Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes
|
journal
|
July 2019 |
|
Anti-idiotypic antibodies elicit anti-HIV-1–specific B cell responses
|
journal
|
July 2019 |
|
Neutralizing Antibodies Administered Before, but Not After, Virulent SHIV Prevent Infection in Macaques
|
journal
|
August 1998 |
|
IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis
|
journal
|
May 2008 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Towards automated crystallographic structure refinement with phenix.refine
|
journal
|
March 2012 |
|
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
|
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|
journal
|
July 2010 |
|
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
|
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
|
journal
|
July 2011 |
|
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
|
journal
|
July 2011 |
|
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
|
journal
|
August 2011 |
|
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
|
journal
|
October 2011 |
|
Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
|
journal
|
May 2013 |
|
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
|
journal
|
March 2013 |
|
Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies
|
journal
|
December 2014 |
|
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
|
journal
|
June 2015 |
|
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
|
journal
|
March 2016 |
|
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice
|
journal
|
September 2016 |
|
Structural basis of a shared antibody response to SARS-CoV-2
|
journal
|
July 2020 |
|
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen
|
journal
|
July 2018 |
|
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
|
journal
|
March 2015 |
|
Antibody and Antiretroviral Preexposure Prophylaxis Prevent Cervicovaginal HIV-1 Infection in a Transgenic Mouse Model
|
journal
|
May 2013 |
|
Diverse Recombinant HIV-1 Envs Fail To Activate B Cells Expressing the Germline B Cell Receptors of the Broadly Neutralizing Anti-HIV-1 Antibodies PG9 and 447-52D
|
journal
|
December 2013 |
|
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design
|
journal
|
February 2012 |
|
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
|
journal
|
January 1999 |
|
Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro
|
journal
|
September 2001 |
|
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
|
journal
|
May 2016 |
|
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
|
journal
|
January 2010 |
|
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
|
journal
|
January 2013 |
|
Structural basis for germline antibody recognition of HIV-1 immunogens
|
journal
|
March 2016 |
|
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
|
journal
|
November 2018 |